¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹À¯¹æ¾ÏÇÐȸ 2019 Ãß°èÇмú´ëȸ : 2019-10-19

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹À¯¹æ¾ÏÇÐȸ 2019 Ãß°èÇмú´ëȸ : 2019-10-19
±³À°ÀÏÀÚ : 2019-10-19
±³À°Àå¼Ò : Á¦ÁֽŶóÈ£ÅÚ 3Ãþ ·ÎÅͽº  
±³À°ÁÖÁ¦ : 2019 Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : Çѱ¹À¯¹æ¾ÏÇÐȸ
´ã´çÀÚ : Á¤Áö¿µ
¿¬¶ôó : 02-3461-6060  
À̸ÞÀÏ : kbcs@kbcs.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú      
Âü¼®¿¹»óÀοø : 350¸í
Èñ¸ÁÆòÁ¡ : 2Á¡  
Áö¿ª : Á¦ÁÖƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 7 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 180,000¿ø      
ºñ°í Àü¹®ÀÇ 1Â÷ 150,000¿ø 2Â÷ 180,000¿ø Àü°øÀÇ/°£È£»ç 1Â÷ 100,000¿ø 2Â÷ 130,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº1 09:00~09:20 Parity affects Breast Cancer-Specific Survival differently in DCIS and Invasive Cancer: A Registry-Based Retrospective Study from Korea  ÀÌÁ¤¼±(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº1 09:20~09:40 Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?  À̼¼°æ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº1 09:40~10:00 Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society  ¹Ú¼º¹Î(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº1 10:00~10:15 Çѱ¹À¯¹æ¾ÏÇÐȸ µî·Ï»ç¾÷ÀÇ ÇöÀç¿Í ¹Ì·¡  ±èÈñÁ¤(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº2 09:00~09:25 À¯¹æÀç°Ç¼ú ȯÀÚÀÇ ¾î·Á¿ò Æò°¡ ¹× µµ¿ÍÁֱ⠠Á¤ºÎ¿¬(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº2 09:25~09:50 ¸é¿ªÇ×¾ÏÄ¡·á ȯÀÚÀÇ ¾î·Á¿ò Æò°¡ ¹× µµ¿ÍÁֱ⠠¾ÈÀÚ¿µ(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº2 09:50~10:15 ÀüÀ̼º À¯¹æ¾Ï ȯÀÚÀÇ ¾î·Á¿ò Æò°¡ ¹× µµ¿ÍÁֱ⠠ÇϼöÁø(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº3 09:00~09:25 Application of Volume Displacement and Replacement Oncoplastic Surgery technique  À̼®¿ø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº3 09:25~09:50 Textured implants vs. smooth implants  ¼º¹Î±â(¿øÀڷº´¿ø) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº3 09:50~10:15 Sub-pectoral reconstruction vs. Pre-pectoral reconstruction  ÇãÂù¿µ(¼­¿ïÀÇ´ë) 
È޽Ġ10-19  10:15~10:30 Coffee break  () 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº1 10:30~10:45 Intro - VAB 20³âÀÌ À¯¹æ Áø·á¿¡ ¹ÌÄ£ ¿µÇâ  ±èÁ¤°æ(¸¶¸®¾ÆÀ¯¿Ü°ú) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº1 10:45~11:45 ÆгÎÅäÀÇ ¹× ûÁß Âü¿© ;VABÀÇ Àû¿ë °¡´É ¹üÀ§¿¡ ´ëÇÏ¿©.  ÇÑ¿ø½Ä ¿Ü 5¸í(¼­¿ïÀÇ´ë ¿Ü) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº2 10:30~10:45 Establishment of educational programs and multicenter study for robotic mastectomy in Korea  ¹ÚÇü¼®(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº2 10:45~11:00 How to develop educational programs for robot, endoscopic, and minimal access breast surgery in Daegu  À̹«Çö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº2 11:00~11:15 Loadmap for effective collaborations in Korea Robot-Endoscopy & Minimal Access Breast Surgery study Group  ½ÅÇõÀç(ÇѾçÀÇ´ë) 
Åä·Ð 10-19 3Ãþ ·ÎÅͽº2 11:15~11:45 panel discussion  () 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº3 10:30~10:55 Neoadjuvant treatment options by breast cancer subtype in Korean health insurance system  ½É¼ºÈÆ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº3 10:55~11:20 Surgery for good responders after Neoadjuvant treatment  ÀÌÇѺ°(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-19 3Ãþ ·ÎÅͽº3 11:20~11:45 Management of early and late complications of chemotherapy and targeted therapy  Á¤½ÂÇÊ(°í·ÁÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹À¯¹æ¾ÏÇÐȸ 2019 Ãß°èÇмú´ëȸ : 2019-10-19""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °í·Á´ëÇб³¾È¾Ïº´¿ø 2019³â ³»°ú °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2019-10-19
´ÙÀ½±Û ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ´ëÀüÁöȸ ¿¬¼ö±³À°(ºÎÀξÏ) : 2019-10-18
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 4 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 8 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 9 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 8 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 5 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 8 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 9 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 9 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 5 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 2 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 4 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 8 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 3 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 4 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 5 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷